批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2024/06/24 |
SUPPL-18(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2022/09/21 |
SUPPL-14(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2022/09/21 |
SUPPL-13(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2022/09/21 |
SUPPL-8(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2022/09/21 |
SUPPL-3(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2019/06/24 |
SUPPL-10(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
2012/12/06 |
SUPPL-2(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2012/03/26 |
SUPPL-1(补充) |
Approval |
Labeling |
|
|
|
2010/06/08 |
ORIG-1(原始申请) |
Approval |
|
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:SULFAMETHOXAZOLE; TRIMETHOPRIM 剂型/给药途径:SUSPENSION;ORAL 规格:200MG/5ML;40MG/5ML 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
018615 |
001 |
NDA |
SULFATRIM PEDIATRIC |
SULFAMETHOXAZOLE; TRIMETHOPRIM |
SUSPENSION;ORAL |
200MG/5ML;40MG/5ML |
Prescription |
No |
No |
AB |
1983/01/07
|
PHARM ASSOC |
074650 |
001 |
ANDA |
SULFAMETHOXAZOLE AND TRIMETHOPRIM |
SULFAMETHOXAZOLE; TRIMETHOPRIM |
SUSPENSION;ORAL |
200MG/5ML;40MG/5ML |
Discontinued |
No |
No |
AB |
1997/12/29
|
HIKMA |
077612 |
001 |
ANDA |
SULFAMETHOXAZOLE AND TRIMETHOPRIM |
SULFAMETHOXAZOLE; TRIMETHOPRIM |
SUSPENSION;ORAL |
200MG/5ML;40MG/5ML |
Prescription |
No |
No |
AB |
2006/11/13
|
PRASCO |
077785 |
001 |
ANDA |
SULFAMETHOXAZOLE AND TRIMETHOPRIM |
SULFAMETHOXAZOLE; TRIMETHOPRIM |
SUSPENSION;ORAL |
200MG/5ML;40MG/5ML |
Prescription |
No |
No |
AB |
2007/01/24
|
CHARTWELL MOLECULAR |
091348 |
001 |
ANDA |
SULFAMETHOXAZOLE AND TRIMETHOPRIM |
SULFAMETHOXAZOLE; TRIMETHOPRIM |
SUSPENSION;ORAL |
200MG/5ML;40MG/5ML |
Prescription |
No |
Yes |
AB |
2010/06/08
|
AUROBINDO PHARMA |
214330 |
001 |
ANDA |
SULFAMETHOXAZOLE AND TRIMETHOPRIM |
SULFAMETHOXAZOLE; TRIMETHOPRIM |
SUSPENSION;ORAL |
200MG/5ML;40MG/5ML |
Prescription |
No |
No |
AB |
2022/02/08
|
NOVITIUM PHARMA |